Modification of Asp–Peptide Adapters: Giving the FAP-Targeted Radioligand a “Squirrel Tail”
Journal of Medicinal Chemistry · 2025
DOI: 10.1021/acs.jmedchem.4c03133 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, 2025. Verfasst von Lingxin Meng und 11 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Vaccines for Infectious Diseases, Center for Molecular Imaging and Translational Medicine, Xiang An Biomedicine Laboratory, S…. Hauptthemen laut MEDLINE: Gallium Radioisotopes, Radiopharmaceuticals, Fluorine Radioisotopes. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: China Postdoctoral Science Foundation, National Natural Science Foundation of China, Xiamen University.
Abstract (Originalsprache)
Fibroblast activation protein (FAP) is a promising target for cancer theranostics, but most FAP-targeted radioprobes showed relatively insufficient tumor uptake and retention, which seriously hampered their further application. Inspired by the squirrel tail, this study developed a novel FAP-targeted molecule, FSND3, which is modified with three Asp-peptide adapters to enable both 68Ga ([68Ga]Ga-FSND3) and 18F ([18F]AlF-FSND3) PET imaging. Compared to [68Ga]Ga-FAPI-04, [68Ga]Ga-FAPI-42, and [18F]AlF-FAPI-42, [18F]AlF-FSND3 and [68Ga]Ga-FSND3 showed enhanced tumor uptake and prolonged residence in HT-1080-FAP and pancreatic tumor models, demonstrating the effectiveness of Asp-peptide adapters in pharmacomodulating FAP-targeted radioligands. The first-in-human pilot study revealed that [18F]AlF- and [68Ga]Ga-FSND3 exhibited comparable uptake in the primary lesion, higher-contrast images, and higher uptake in some metastases like in bone and brain, to 2-[18F] FDG PET/CT imaging. As a proof of concept, these results offer a significant enhancement to the diversity of the FAP-targeted tracer arsenal.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Vaccines for Infectious Diseases, Center for Molecular Imaging and Translational Medicine, Xiang An Biomedicine Laboratory, School of Public Health, Xiamen University, 4221-116 Xiang'An South Rd,…
- Department of Nuclear Medicine, the First Affiliated Hospital, Fujian Medical University, No. 20 Chazhong Road, Taijiang District, Fuzhou 350005, China.
- Theranostics and Translational Research Center, Institute of Clinical Medicine, Department of Nuclear Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College,…
ORCID-Profile: Xianzhong Zhang, Zhide Guo
Förderung
- China Postdoctoral Science Foundation
- National Natural Science Foundation of China
- Xiamen University
- Joint Funds for the Innovation of Science and Technology, Fujian Province
- Scientific Research Foundation of State Key Laboratory of Vaccines for Infectious Diseases, Xiang An Biomedicine Laboratory
- National High-Level Hospital Clinical Research Funding
Zitieren
APA
Meng, L., Lin, R., Zhang, J., Li, H., Xia, D., Zhao, Z., Zhuang, R., Huang, L., Zhang, X., Fang, J., Miao, W., & Guo, Z. (2025). Modification of Asp–Peptide Adapters: Giving the FAP-Targeted Radioligand a “Squirrel Tail”. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.4c03133
Vancouver
Meng L, Lin R, Zhang J, Li H, Xia D, Zhao Z, et al. Modification of Asp–Peptide Adapters: Giving the FAP-Targeted Radioligand a “Squirrel Tail”. Journal of Medicinal Chemistry. 2025. doi:10.1021/acs.jmedchem.4c03133
BibTeX
@article{Meng2025,
author = {Meng, Lingxin and Lin, Rong and Zhang, Jingru and Li, Huifeng and Xia, Dongsheng and Zhao, Zuoquan and Zhuang, Rongqiang and Huang, Lumei and Zhang, Xianzhong and Fang, Jianyang and Miao, Weibing and Guo, Zhide},
title = {Modification of Asp–Peptide Adapters: Giving the FAP-Targeted Radioligand a “Squirrel Tail”},
journal = {Journal of Medicinal Chemistry},
year = {2025},
doi = {10.1021/acs.jmedchem.4c03133}
}
EUVIMED